Browse Pet Safety Reports
18,010 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 18,010 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 18,010 FDA veterinary adverse event reports for Horse.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Jun 24, 2025 | Horse | Oldenburg | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Jun 24, 2025 | Horse | Irish Cob (Tinker) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jun 24, 2025 | Horse | Thoroughbred | Ceftiofur Crystalline Free Acid | Injection site swelling; Fever; Myositis; Abnormal ultrasound finding; Abnorm... | Ongoing |
| Jun 23, 2025 | Horse | Hanovarian | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jun 21, 2025 | Horse | Quarter Horse | Diclofenac Sodium | Residues NOS | Outcome Unknown |
| Jun 20, 2025 | Horse | Warmblood - Dutch | Ceftiofur Crystalline Free Acid | Lethargy (see also Central nervous system depression in Neurological); Fever;... | Ongoing |
| Jun 20, 2025 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jun 19, 2025 | Horse | Paint | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Jun 19, 2025 | Horse | Friesian | Firocoxib | Leucopenia NOS; Neutropenia | Outcome Unknown |
| Jun 19, 2025 | Horse | Quarter Horse | Omeprazole | Itchy skin; Skin lesion NOS; Urticaria; Behavioural disorder NOS; Bumps on sk... | Outcome Unknown |
| Jun 19, 2025 | Horse | Thoroughbred | Ceftiofur Crystalline Free Acid | Injection site abscess; Injection site swelling; Cellulitis; Injection site n... | Ongoing |
| Jun 19, 2025 | Horse | Warmblood (unspecified) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jun 19, 2025 | Horse | Quarter Horse | Altrenogest Oily Solution | Itchy skin; Skin lesion NOS; Urticaria; Bumps on skin; Hypersensitivity react... | Outcome Unknown |
| Jun 18, 2025 | Horse | Thoroughbred | Pentosan Polysulfate Sodium | Injection site hair change | Outcome Unknown |
| Jun 18, 2025 | Horse | Warmblood (unspecified) | Omeprazole | INEFFECTIVE, GASTRIC ULCER(S) | Outcome Unknown |
| Jun 16, 2025 | Horse | Quarter Horse | Ciclesonide | Lack of efficacy - NOS; Broken components, medical device | Outcome Unknown |
| Jun 16, 2025 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jun 16, 2025 | Horse | Morgan | Pergolide Mesylate | Fever; Elevated liver enzymes NOS | Outcome Unknown |
| Jun 15, 2025 | Horse | Quarter Horse | Hyaluronate Sodium | Seizure NOS; Death by euthanasia; Behavioural disorder NOS | Euthanized |
| Jun 15, 2025 | Horse | Oldenburg | Enrofloxacin | Seizure NOS; Death by euthanasia; Lying down | Euthanized |
| Jun 15, 2025 | Horse | Quarter Horse | Pentosan Polysulfate Sodium | Pruritus; Hives (see also Skin); Tachycardia; Hypersensitivity NOS | Recovered/Normal |
| Jun 13, 2025 | Horse | Quarter Horse | Pentosan Polysulfate Sodium | Injection site swelling | Recovered/Normal |
| Jun 13, 2025 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Jun 13, 2025 | Horse | Quarter Horse | Ivermectin; Praziquantel | Chemical burn; Oral swelling | Recovered/Normal |
| Jun 12, 2025 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Jun 12, 2025 | Horse | Horse (unknown) | Hyaluronate Sodium | Injection site inflammation | Outcome Unknown |
| Jun 11, 2025 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Jun 11, 2025 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Jun 11, 2025 | Horse | Westphalian | Omeprazole | Behavioural disorder NOS | Outcome Unknown |
| Jun 10, 2025 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jun 10, 2025 | Horse | Quarter Horse, Horse (other) | Ceftiofur Crystalline Free Acid | Lack of efficacy - NOS; Intentional misuse | Ongoing |
| Jun 10, 2025 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Jun 9, 2025 | Horse | Pony of the Americas | Ivermectin | Lack of efficacy - NOS; Death by euthanasia | Euthanized |
| Jun 8, 2025 | Horse | Horse (unknown) | Pergolide Mesylate | Nasal bleeding | Outcome Unknown |
| Jun 8, 2025 | Horse | Quarter Horse | Ceftiofur Crystalline Free Acid | Collapse (see also Cardio-vascular and Systemic disorders); Dyspnoea; Hives (... | Euthanized |
| Jun 7, 2025 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jun 7, 2025 | Horse | Horse (other) | Pentosan Polysulfate Sodium | Injection site swelling; Abnormal serum protein NOS | Outcome Unknown |
| Jun 6, 2025 | Horse | Horse (other) | Omeprazole | INEFFECTIVE, GASTRIC ULCER(S) | Outcome Unknown |
| Jun 6, 2025 | Horse | Friesian | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Jun 6, 2025 | Horse | Unknown | Sodium Hyaluronate | Joint swelling | Outcome Unknown |
| Jun 6, 2025 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jun 6, 2025 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jun 6, 2025 | Horse | Warmblood (unspecified) | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Jun 5, 2025 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jun 5, 2025 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Jun 5, 2025 | Horse | Warmblood - Dutch, Warmbloo... | Ketamine Hydrochloride | Lack of efficacy - NOS | Recovered/Normal |
| Jun 5, 2025 | Horse | Morgan | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Jun 5, 2025 | Horse | Hanovarian | Diclazuril Oral Pellets | Gastric ulcer; Hives (see also Skin); Skin disorders NOS; Weight loss; Off fo... | Ongoing |
| Jun 5, 2025 | Horse | Quarter Horse | Methylprednisolone Acetate | Collapse (see also Cardio-vascular and Systemic disorders); Pale mucous membr... | Died |
| Jun 5, 2025 | Horse | Quarter Horse | Butorphanol Injectable | Collapse (see also Cardio-vascular and Systemic disorders); Pale mucous membr... | Died |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.